1Cattran D. Management of membranous nephropathy:when and what for treatment [ J ]. J Am Soc Nephro1,2005 ,16 (5) : 1188-1194.
2Lai KN. Membranous nephropathy: When and how to treat [ J ], Kidney Int ,2007,71 (9) :841-843.
3Shiiki H, Saito T, Nishitani T, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephritic syndrome in Japan [ J]. Kidney Int,2004,65 (4) :1400-1407.
4Ponticelli C, Zucchelli P, Passerini P, et al. A 10-yuar follow-up a randomized study with methylprednisolone and chloramhucil in membranous nephropathy [ J ]. Kidney lnt, 1995,48 ( 15 ) : 1600 - 1604.
5du Buf-Vereijken PW, Branten A J, Wetzels JF, et al. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate [ J ]. Nephrol Dial Transplant, 2004,19 (5) :1142-1148.
6Jha V, Ganguli A, Saha TK, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy [ J ]. J Am Suc Nephrol, 2007,18(6) : 1899-1904.
7Dede F, Ayili D, Sahiner S. Effective treatment administration of cyclophosphamide in membranous nephropathy [ J ]. J Nephrol, 2008, 214 : 560 -565.
8Ahuja M, Goumenos D, Shortland JR, et al. Does immunosuppression with prednlsolone and azathioprine alter the progression of idiopathic membranous nephropathy [ J ]. Am J Kidney Dis, 1999,34 (3) :521- 529.
9Goumenos DS, Ahuja M, Davlouros P,et al. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study [ J]. Clin Nephrol,2006 ,65 (5) :317-323.
10Cattran DC, Appel GB, Hebert LA ,et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial [ J ]. Kidney Int,2001,59 (4) : 1484-1490.
9Donadio JV, Torres VE, Velosa JA, et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int, 1988,33:708 -715.
10Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China:Analysis based on 13,519 renal biopsies. Kidney Int, 2004, 66:920 - 923.